Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
| ▸ | NPC1 | O15118 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30989216 | 1.00 | MEN1 (0.63) | MEN1KMT2AKDM4ESMN1; SMN2HPGD | |
| SCHEMBL17908051 | 0.86 | TSHR (0.64) | MEN1KMT2AKDM4ERAB9APOLB | |
| SCHEMBL17908100 | 0.86 | TSHR (0.64) | MEN1KMT2AKDM4ERAB9APOLB | |
| SCHEMBL6087221 | 0.85 | MAPK1 (0.65) | MEN1KMT2AKDM4ESMN1; SMN2POLB | |
| SCHEMBL28080921 | 0.83 | MEN1 (0.66) | MEN1KMT2AKDM4ESMN1; SMN2HPGD | |
| SCHEMBL515746 | 0.81 | MEN1 (0.73) | MEN1KMT2AKDM4ESMN1; SMN2HPGD | |
| SCHEMBL29578705 | 0.81 | MEN1 (0.73) | MEN1KMT2AKDM4ESMN1; SMN2HPGD | |
| SCHEMBL6087260 | 0.81 | CYP1A2 (0.59) | KDM4ESMN1; SMN2POLBCYP1A2CYP3A4 | |
| SCHEMBL27816792 | 0.79 | MEN1 (0.68) | MEN1KMT2AKDM4ESMN1; SMN2HPGD | |
| SCHEMBL12180774 | 0.77 | CYP1A2 (0.66) | MEN1KMT2AKDM4ESMN1; SMN2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7462606-B2 | Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring | FIDIA FARMACEUTICI S.P.A. (IT) | 2008-12-09 | — | — | US | claimed |
| EP-1519962-B1 | ESTER DERIVATIVES OF HYALURONIC ACID FOR THE PREPARATION OF HYDROGEL MATERIALS BY PHOTOCURING | FIDIA FARMACEUTICI (IT) | 2007-09-12 | — | — | EP | claimed |
| US-20050119219-A1 | Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring | FIDIA FARMACEUTICI S.P.A. (IT) | 2005-06-02 | — | — | US | claimed |
| EP-1519962-A1 | ESTER DERIVATIVES OF HYALURONIC ACID FOR THE PREPARATION OF HYDROGEL MATERIALS BY PHOTOCURING | FIDIA ADVANCED BIOPOLYMERS, S.R.L. (IT) | 2005-04-06 | — | — | EP | claimed |
| WO-2003076475-A1 | ESTER DERIVATIVES OF HYALURONIC ACID FOR THE PREPARATION OF HYDROGEL MATERIALS BY PHOTOCURING | FIDIA ADVANCED BIOPOLYMERS S.R.L. (IT) | 2003-09-18 | — | — | WO | claimed |
| US-20240392220-A1 | BRANDY REPLICAS | AVA FOOD LABS, INC. | 2024-11-28 | — | — | US | disclosed |
| CN-118339274-A | Brandy replica | 艾娃食品实验室股份有限公司 | 2024-07-12 | — | — | CN | disclosed |
| US-8178663-B2 | Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring | FIDIA FARMACEUTICI S.P.A. (IT) | 2012-05-15 | — | — | US | disclosed |
| US-8178499-B2 | Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring | FIDIA FARMACEUTICI S.P.A. (IT) | 2012-05-15 | — | — | US | disclosed |
| US-20090076257-A1 | Ester Derivatives of Hyaluronic Acid for the Preparation of Hydrogel Materials by Photocuring | FIDIA FARMACEUTICI S.P.A. (IT) | 2009-03-19 | — | — | US | disclosed |
| US-20090075911-A1 | Ester Derivatives of Hyaluronic Acid for the Preparation of Hydrogel Materials by Photocuring | FIDIA ADVANCED BIOPOLYMERS S.R.L. (IT) | 2009-03-19 | — | — | US | disclosed |
| US-7462606-B2 | Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring | FIDIA FARMACEUTICI S.P.A. (IT) | 2008-12-09 | — | — | US | disclosed |
| EP-1519962-B1 | ESTER DERIVATIVES OF HYALURONIC ACID FOR THE PREPARATION OF HYDROGEL MATERIALS BY PHOTOCURING | FIDIA FARMACEUTICI (IT) | 2007-09-12 | — | — | EP | disclosed |
| US-20050119219-A1 | Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring | FIDIA FARMACEUTICI S.P.A. (IT) | 2005-06-02 | — | — | US | disclosed |
| EP-1519962-A1 | ESTER DERIVATIVES OF HYALURONIC ACID FOR THE PREPARATION OF HYDROGEL MATERIALS BY PHOTOCURING | FIDIA ADVANCED BIOPOLYMERS, S.R.L. (IT) | 2005-04-06 | — | — | EP | disclosed |
| WO-2003076475-A1 | ESTER DERIVATIVES OF HYALURONIC ACID FOR THE PREPARATION OF HYDROGEL MATERIALS BY PHOTOCURING | FIDIA ADVANCED BIOPOLYMERS S.R.L. (IT) | 2003-09-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090075911-A1 | Ester Derivatives of Hyaluronic Acid for the Preparation of Hydrogel Materials by Photocuring | CD44, HPSE, HPGDS | MEN1 2703/4885KMT2A 4638/4885KDM4E 3271/4885 |
| US-20050119219-A1 | Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring | CD44, HPSE, HPGDS | MEN1 2703/4885KMT2A 4638/4885KDM4E 3271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.